Cargando…

Mitochondrial quality control in diabetic cardiomyopathy: from molecular mechanisms to therapeutic strategies

In diabetic cardiomyopathy (DCM), a major diabetic complication, the myocardium is structurally and functionally altered without evidence of coronary artery disease, hypertension or valvular disease. Although numerous anti-diabetic drugs have been applied clinically, specific medicines to prevent DC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Chen, Wu, Feng, He, Jing, Zhang, Yaoyuan, Shi, Nengxian, Peng, Xiaojie, Ou, Qing, Li, Ziying, Jiang, Xiaoqing, Zhong, Jiankai, Tan, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461654/ https://www.ncbi.nlm.nih.gov/pubmed/36147470 http://dx.doi.org/10.7150/ijbs.75402

Ejemplares similares

Empagliflozin activates Wnt/β-catenin to stimulate FUNDC1-dependent mitochondrial quality surveillance against type-3 cardiorenal syndrome
por: Cai, Chen, et al.
Publicado: (2022)

Dual specificity phosphatase 1 attenuates inflammation-induced cardiomyopathy by improving mitophagy and mitochondrial metabolism
por: Tan, Ying, et al.
Publicado: (2022)

Therapeutic strategies in ischemic cardiomyopathy: Focus on mitochondrial quality surveillance
por: Chang, Xing, et al.
Publicado: (2022)

Pgam5-mediated PHB2 dephosphorylation contributes to endotoxemia-induced myocardial dysfunction by inhibiting mitophagy and the mitochondrial unfolded protein response
por: Cai, Chen, et al.
Publicado: (2023)

Novel Insights into the Molecular Features and Regulatory Mechanisms of Mitochondrial Dynamic Disorder in the Pathogenesis of Cardiovascular Disease
por: Tan, Ying, et al.
Publicado: (2021)

Molecular Mechanisms of Mitochondrial Quality Control in Ischemic Cardiomyopathy
por: Chang, Xing, et al.
Publicado: (2023)

Therapeutic contribution of melatonin to the treatment of septic cardiomyopathy: A novel mechanism linking Ripk3-modified mitochondrial performance and endoplasmic reticulum function
por: Zhong, Jiankai, et al.
Publicado: (2019)

Mitochondrial Cardiomyopathy: Molecular Epidemiology, Diagnosis, Models, and Therapeutic Management
por: Yang, Jinjuan, et al.
Publicado: (2022)

Editorial: Mitochondrial and lysosomal dysfunction in neurodegenerative diseases: Molecular mechanisms and therapeutic strategies
por: Xiang, Chen, et al.
Publicado: (2022)

Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway
por: Cai, Chen, et al.
Publicado: (2022)

Corrigendum to “Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway” [Redox Biol. 52 (2022) 102288]
por: Cai, Chen, et al.
Publicado: (2023)

Mitochondrial Quality Control Mechanisms during Diabetic Cardiomyopathy
por: Ketenci, Melis, et al.
Publicado: (2022)

Mitochondrial Cardiomyopathies
por: El-Hattab, Ayman W., et al.
Publicado: (2016)

Mitochondrial Quality Control Strategies: Potential Therapeutic Targets for Neurodegenerative Diseases?
por: Hu, Di, et al.
Publicado: (2021)

Molecular Epidemiology of Mitochondrial Cardiomyopathy: A Search Among Mitochondrial and Nuclear Genes
por: Mazzaccara, Cristina, et al.
Publicado: (2021)

The Role of Mitochondria in Pyroptosis
por: Li, Qian, et al.
Publicado: (2021)

Mitochondrial Dysfunction in Diabetic Cardiomyopathy: The Possible Therapeutic Roles of Phenolic Acids
por: Jubaidi, Fatin Farhana, et al.
Publicado: (2020)

Molecular Correlates of Early Onset of Diabetic Cardiomyopathy: Possible Therapeutic Targets
por: Wang, Dongjuan, et al.
Publicado: (2022)

Arrhythmogenic Cardiomyopathy: Molecular Insights for Improved Therapeutic Design
por: Stevens, Tyler L., et al.
Publicado: (2020)

Therapeutic strategies utilizing SDF-1α in ischaemic cardiomyopathy
por: Ziff, Oliver J, et al.
Publicado: (2018)

Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy
por: Sun, Huiyan, et al.
Publicado: (2023)

Targeting mitochondrial dynamics by regulating Mfn2 for therapeutic intervention in diabetic cardiomyopathy
por: Hu, Lang, et al.
Publicado: (2019)

Mitochondrial Dynamics Imbalance: A Strategy for Promoting Viral Infection
por: Ren, Zhihua, et al.
Publicado: (2020)

Current Studies of Mitochondrial Quality Control in the Preeclampsia
por: Peng, Xiaoqing, et al.
Publicado: (2022)

Gut microbiota: A new therapeutic target for diabetic cardiomyopathy
por: Yuan, Suxin, et al.
Publicado: (2022)

Whole mitochondrial genome sequencing of Malaysian patients with cardiomyopathy
por: Kuan, Sheh Wen, et al.
Publicado: (2022)

Mitochondrial Transplantation as a Novel Therapeutic Strategy for Mitochondrial Diseases
por: Park, Anna, et al.
Publicado: (2021)

Diagnostic and therapeutic strategies for arrhythmogenic right ventricular dysplasia/cardiomyopathy patient
por: Wang, Weijia, et al.
Publicado: (2019)

Targeting lipid metabolism as a new therapeutic strategy for inherited cardiomyopathies
por: Gaar-Humphreys, Karen R., et al.
Publicado: (2023)

Left ventricular hypertrophy with cardiomyocyte atrophy and extensive interstitial fibrosis: a mitochondrial cardiomyopathy
por: Zhang, Xinyu, et al.
Publicado: (2022)

Irisin Attenuates Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in the H9C2 Cellular Model of Septic Cardiomyopathy through Augmenting Fundc1-Dependent Mitophagy
por: Jiang, Xiaoqing, et al.
Publicado: (2021)

Mitochondrial Mechanisms in Septic Cardiomyopathy
por: Cimolai, María Cecilia, et al.
Publicado: (2015)

Mitochondrial Mechanisms in Diabetic Cardiomyopathy
por: Gollmer, Johannes, et al.
Publicado: (2020)

Mitochondrial Protein Homeostasis and Cardiomyopathy
por: Wachoski-Dark, Emily, et al.
Publicado: (2022)

Therapeutic Approach of Flavonoid in Ameliorating Diabetic Cardiomyopathy by Targeting Mitochondrial-Induced Oxidative Stress
por: Sapian, Syaifuzah, et al.
Publicado: (2021)

Therapeutic Strategies for Regulating Mitochondrial Oxidative Stress
por: Yamada, Yuma, et al.
Publicado: (2020)

Mitochondrially-Targeted Therapeutic Strategies for Alzheimer’s Disease
por: Onyango, Isaac G., et al.
Publicado: (2021)

Mitochondrial Dysfunction in Cardiac Diseases and Therapeutic Strategies
por: Huang, Yafei, et al.
Publicado: (2023)

1-Deoxynojirimycin promotes cardiac function and rescues mitochondrial cristae in mitochondrial hypertrophic cardiomyopathy
por: Zhuang, Qianqian, et al.
Publicado: (2023)

CaMKII Inhibition is a Novel Therapeutic Strategy to Prevent Diabetic Cardiomyopathy
por: Veitch, Christopher R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_umvv7tmvqhc3rslusqbnl8c23l